-transparent.png){kind=logo}
The aim of this work was to investigate the influence of blood pressure levels on human platelet alpha 2-adrenergic receptivity. The study was carried out on 12 mild essential hypertensive patients and 7 normotensive parkinsonians with orthostatic hypotension. Alpha 2-adrenoceptors number and affinity were determined by 3H-yohimbine binding, plasma catecholamines were measured by HPLC and adrenaline-induced platelet aggregation by turbidimetry. Results obtained were compared with those of two groups of 12 normotensive control subjects. In hypertensive patients, both platelet alpha 2-adrenoceptors (139 +/- 6 vs 176 +/- 18 fmol/mg protein) and velocity of adrenaline-induced platelet aggregation were decreased whereas plasma adrenaline and noradrenaline remained unchanged. In patients with orthostatic hypotension, there was an increased number of platelet alpha 2-adrenoceptors (313 +/- 52 vs 168 +/- 8 fmol/mg protein) associated with a significant decrease in plasma noradrenaline (62 +/- 11 vs 190 +/- 25 pg/ml). In none of the two groups of patients there was any change in receptor affinity for 3H-yohimbine. These results indicate that human platelet alpha 2-adrenoceptors levels are related to blood pressure values. Moreover, up-regulation in orthostatic hypotension and lack of down-regulation in essential hypertension suggest that only sustained abnormal plasma noradrenaline levels could allow the development of alpha 2-adrenoceptors regulatory mechanisms. These variations can represent tentative compensatory mechanisms for normalization of blood pressure levels.
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
March 1986,
The American journal of cardiology,
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
January 1992,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
January 1987,
Hypertension (Dallas, Tex. : 1979),
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
July 2002,
Presse medicale (Paris, France : 1983),
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
January 1991,
Kardiologia polska,
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
May 1982,
Lancet (London, England),
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
April 1982,
Lancet (London, England),
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
May 1985,
Pharmacology, biochemistry, and behavior,
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
February 1992,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
J M Senard, and
P Valet, and
M Galinier, and
M A Tran, and
F Galinier, and
B Boneu, and
J L Montastruc
January 1983,
International review of neurobiology,
